Return
Concerns about Anavex's clinical trial of Blarcamesine
B
DOI:10.1016/j.tjpad.2025.100137.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
J
IF:
7.8
Papers:
841
Citations:
3.1K
Organization
No organization information available
